Research output per year
Research output per year
Search results
-
2022
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN
Nooka, A. K., Kaufman, J. L., Rodriguez, C., Jakubowiak, A., Efebera, Y., Reeves, B., Wildes, T., Holstein, S. A., Anderson, L. D., Badros, A., Shune, L., Chari, A., Pei, H., Cortoos, A., Patel, S., Bartlett, J. B., Vermeulen, J., Lin, T. S., Richardson, P. G. & Voorhees, P., Apr 2022, In: Blood Cancer Journal. 12, 4, 63.Research output: Contribution to journal › Letter › peer-review
Open Access5 Scopus citations -
2021
The proteomic landscape of pancreatic ductal adenocarcinoma liver metastases identifies molecular subtypes and associations with clinical response—response
Law, H. C. H., Clement, E. J., Grandgenett, P. M., Hollingsworth, M. A. & Woods, N. T., Jul 2021, In: Clinical Cancer Research. 27, 14, p. 4127 1 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Scopus citations -
2019
The miR-17~92 cluster activates mTORC1 in mantle cell lymphoma by targeting multiple regulators in the STK11/AMPK/TSC/mTOR pathway
Jiang, C., Bi, C., Jiang, X., Tian, T., Huang, X., Wang, C., Fernandez, M. R., Iqbal, J., Chan, W. C., McKeithan, T. W., Lewis, R. E. & Fu, K., May 2019, In: British Journal of Haematology. 185, 3, p. 616-620 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access11 Scopus citations